Institutional investors purchased a net $6.4 million shares of GSK during the quarter ended March 2016 and now own 8.65% of the total shares outstanding. This is a greater percentage than is typical for companies in the Pharmaceuticals: Major industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
FIDELITY MANAGEMENT & RESEARCH C... Bought 1.9 Million shares of GlaxoSmithKline
OSTERWEIS CAPITAL MANAGEMENT, IN... Bought 1.0 Million shares of GlaxoSmithKline